Post-TAVR Valve Hemodynamic Deterioration

(1), being the first study to systematically scrutinize valve hemodynamic deterioration (VHD) in a multicenter cohort of patients after transcatheter aortic valve replacement (TAVR). Because there is some evidence suggesting that patient selection criteria are evolving away from the pre-market inclu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2016-07, Vol.68 (2), p.239-239
Hauptverfasser: Deutsch, Marcus-André, MD, Erlebach, Magdalena, MD, Krane, Markus, MD, Lange, Ruediger, MD, PhD, Bleiziffer, Sabine, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 239
container_issue 2
container_start_page 239
container_title Journal of the American College of Cardiology
container_volume 68
creator Deutsch, Marcus-André, MD
Erlebach, Magdalena, MD
Krane, Markus, MD
Lange, Ruediger, MD, PhD
Bleiziffer, Sabine, MD
description (1), being the first study to systematically scrutinize valve hemodynamic deterioration (VHD) in a multicenter cohort of patients after transcatheter aortic valve replacement (TAVR). Because there is some evidence suggesting that patient selection criteria are evolving away from the pre-market inclusion and exclusion criteria, expanding the indications for TAVR to the population of lower-risk and younger patients, close attention is required to determine the long-term durability of transcatheter heart valves.
doi_str_mv 10.1016/j.jacc.2016.03.592
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808671500</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109716329230</els_id><sourcerecordid>4111483621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c516t-d0ec9c36dee36bb5ef9cb1231e01980180db3555309a89d53b41a4f431a972b43</originalsourceid><addsrcrecordid>eNqNkVFL3TAUx4Ns6J3zC_gwLuzFPbSekzRtA2Mg6qYgODb1NaTpuZCubVzSK9xvv9SrG_gwfMp5-P3_5PwOY4cIOQKWx13eGWtznuYcRC4V32ELlLLOhFTVG7aASsgMQVV77F2MHQCUNapdtscrUZdVXSzYp-8-TtnNyd2P5Z3pH2h5QYNvN6MZnF2e0UTB-WAm58f37O3K9JEOnt59dvv1_Ob0Iru6_nZ5enKVWYnllLVAVllRtkSibBpJK2Ub5AIJUNWANbSNkFIKUKZWrRRNgaZYFQKNqnhTiH12tO29D_73muKkBxct9b0Zya-jTg3p7ygBXoPyqgAs6oR-fIF2fh3GtMgjJREEqkTxLWWDjzHQSt8HN5iw0Qh6dq47PTvXs3MNQifnKfThqXrdDNT-jTxLTsDnLUBJ24OjoKN1NFpqXSA76da7__d_eRG3vRudNf0v2lD8t4eOXIP-OV99PjqWgqc4iD_LD6N6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1802510319</pqid></control><display><type>article</type><title>Post-TAVR Valve Hemodynamic Deterioration</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Alma/SFX Local Collection</source><creator>Deutsch, Marcus-André, MD ; Erlebach, Magdalena, MD ; Krane, Markus, MD ; Lange, Ruediger, MD, PhD ; Bleiziffer, Sabine, MD</creator><creatorcontrib>Deutsch, Marcus-André, MD ; Erlebach, Magdalena, MD ; Krane, Markus, MD ; Lange, Ruediger, MD, PhD ; Bleiziffer, Sabine, MD</creatorcontrib><description>(1), being the first study to systematically scrutinize valve hemodynamic deterioration (VHD) in a multicenter cohort of patients after transcatheter aortic valve replacement (TAVR). Because there is some evidence suggesting that patient selection criteria are evolving away from the pre-market inclusion and exclusion criteria, expanding the indications for TAVR to the population of lower-risk and younger patients, close attention is required to determine the long-term durability of transcatheter heart valves.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2016.03.592</identifier><identifier>PMID: 27386784</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aortic Valve - surgery ; Aortic Valve Stenosis - surgery ; Cardiology ; Cardiovascular ; Heart Valve Prosthesis ; Hemodynamics ; Humans ; Internal Medicine ; Risk Factors ; Thrombosis ; Transcatheter Aortic Valve Replacement ; Treatment Outcome</subject><ispartof>Journal of the American College of Cardiology, 2016-07, Vol.68 (2), p.239-239</ispartof><rights>American College of Cardiology Foundation</rights><rights>2016 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jul 12, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c516t-d0ec9c36dee36bb5ef9cb1231e01980180db3555309a89d53b41a4f431a972b43</citedby><cites>FETCH-LOGICAL-c516t-d0ec9c36dee36bb5ef9cb1231e01980180db3555309a89d53b41a4f431a972b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2016.03.592$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27386784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deutsch, Marcus-André, MD</creatorcontrib><creatorcontrib>Erlebach, Magdalena, MD</creatorcontrib><creatorcontrib>Krane, Markus, MD</creatorcontrib><creatorcontrib>Lange, Ruediger, MD, PhD</creatorcontrib><creatorcontrib>Bleiziffer, Sabine, MD</creatorcontrib><title>Post-TAVR Valve Hemodynamic Deterioration</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>(1), being the first study to systematically scrutinize valve hemodynamic deterioration (VHD) in a multicenter cohort of patients after transcatheter aortic valve replacement (TAVR). Because there is some evidence suggesting that patient selection criteria are evolving away from the pre-market inclusion and exclusion criteria, expanding the indications for TAVR to the population of lower-risk and younger patients, close attention is required to determine the long-term durability of transcatheter heart valves.</description><subject>Aortic Valve - surgery</subject><subject>Aortic Valve Stenosis - surgery</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Heart Valve Prosthesis</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Risk Factors</subject><subject>Thrombosis</subject><subject>Transcatheter Aortic Valve Replacement</subject><subject>Treatment Outcome</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkVFL3TAUx4Ns6J3zC_gwLuzFPbSekzRtA2Mg6qYgODb1NaTpuZCubVzSK9xvv9SrG_gwfMp5-P3_5PwOY4cIOQKWx13eGWtznuYcRC4V32ELlLLOhFTVG7aASsgMQVV77F2MHQCUNapdtscrUZdVXSzYp-8-TtnNyd2P5Z3pH2h5QYNvN6MZnF2e0UTB-WAm58f37O3K9JEOnt59dvv1_Ob0Iru6_nZ5enKVWYnllLVAVllRtkSibBpJK2Ub5AIJUNWANbSNkFIKUKZWrRRNgaZYFQKNqnhTiH12tO29D_73muKkBxct9b0Zya-jTg3p7ygBXoPyqgAs6oR-fIF2fh3GtMgjJREEqkTxLWWDjzHQSt8HN5iw0Qh6dq47PTvXs3MNQifnKfThqXrdDNT-jTxLTsDnLUBJ24OjoKN1NFpqXSA76da7__d_eRG3vRudNf0v2lD8t4eOXIP-OV99PjqWgqc4iD_LD6N6</recordid><startdate>20160712</startdate><enddate>20160712</enddate><creator>Deutsch, Marcus-André, MD</creator><creator>Erlebach, Magdalena, MD</creator><creator>Krane, Markus, MD</creator><creator>Lange, Ruediger, MD, PhD</creator><creator>Bleiziffer, Sabine, MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20160712</creationdate><title>Post-TAVR Valve Hemodynamic Deterioration</title><author>Deutsch, Marcus-André, MD ; Erlebach, Magdalena, MD ; Krane, Markus, MD ; Lange, Ruediger, MD, PhD ; Bleiziffer, Sabine, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c516t-d0ec9c36dee36bb5ef9cb1231e01980180db3555309a89d53b41a4f431a972b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aortic Valve - surgery</topic><topic>Aortic Valve Stenosis - surgery</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Heart Valve Prosthesis</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Risk Factors</topic><topic>Thrombosis</topic><topic>Transcatheter Aortic Valve Replacement</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deutsch, Marcus-André, MD</creatorcontrib><creatorcontrib>Erlebach, Magdalena, MD</creatorcontrib><creatorcontrib>Krane, Markus, MD</creatorcontrib><creatorcontrib>Lange, Ruediger, MD, PhD</creatorcontrib><creatorcontrib>Bleiziffer, Sabine, MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deutsch, Marcus-André, MD</au><au>Erlebach, Magdalena, MD</au><au>Krane, Markus, MD</au><au>Lange, Ruediger, MD, PhD</au><au>Bleiziffer, Sabine, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Post-TAVR Valve Hemodynamic Deterioration</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2016-07-12</date><risdate>2016</risdate><volume>68</volume><issue>2</issue><spage>239</spage><epage>239</epage><pages>239-239</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>(1), being the first study to systematically scrutinize valve hemodynamic deterioration (VHD) in a multicenter cohort of patients after transcatheter aortic valve replacement (TAVR). Because there is some evidence suggesting that patient selection criteria are evolving away from the pre-market inclusion and exclusion criteria, expanding the indications for TAVR to the population of lower-risk and younger patients, close attention is required to determine the long-term durability of transcatheter heart valves.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27386784</pmid><doi>10.1016/j.jacc.2016.03.592</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2016-07, Vol.68 (2), p.239-239
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_1808671500
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present); Alma/SFX Local Collection
subjects Aortic Valve - surgery
Aortic Valve Stenosis - surgery
Cardiology
Cardiovascular
Heart Valve Prosthesis
Hemodynamics
Humans
Internal Medicine
Risk Factors
Thrombosis
Transcatheter Aortic Valve Replacement
Treatment Outcome
title Post-TAVR Valve Hemodynamic Deterioration
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T17%3A21%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Post-TAVR%20Valve%20Hemodynamic%20Deterioration&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Deutsch,%20Marcus-Andr%C3%A9,%20MD&rft.date=2016-07-12&rft.volume=68&rft.issue=2&rft.spage=239&rft.epage=239&rft.pages=239-239&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2016.03.592&rft_dat=%3Cproquest_cross%3E4111483621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1802510319&rft_id=info:pmid/27386784&rft_els_id=1_s2_0_S0735109716329230&rfr_iscdi=true